✦ LIBER ✦

Effect of lesion level on the orthotic gait performance in individuals with complete paraplegia

✍ Scribed by Kawashima, N; Taguchi, D; Nakazawa, K; Akai, M

Book ID: 110074951
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 214 KB
Volume: 44
Category: Article
ISSN: 1362-4393
DOI: 10.1038/sj.sc.3101916

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of lesion level on the orthotic g

Effect of lesion level on the orthotic gait performance in individuals with complete paraplegia

✍ Kawashima, N; Taguchi, D; Nakazawa, K; Akai, M 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

The effects of orthotics on gait in chil

The effects of orthotics on gait in children with low level myelomeningocele

✍ Sylvia Õunpuu; Roy B. Davis; Jack V. Banta; Peter A. DeLuca 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Effect of fenofibrate on the level of as

Effect of fenofibrate on the level of asymmetric dimethylarginine in individuals with hypertriglyceridemia

✍ Tian-Lun Yang; Mei-Fang Chen; Xin Xia; Bai-Lin Luo; Yuan-Jian Li 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 131 KB

The effects of reducing fear of falling

The effects of reducing fear of falling on locomotion in older adults with a higher level gait disorder

✍ Y. Balash; M. Hadar-Frumer; T. Herman; C. Peretz; N. Giladi; J. M. Hausdorff 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 121 KB

The effects of body-weight supported tre

The effects of body-weight supported treadmill training on cardiovascular regulation in individuals with motor-complete SCI

✍ Ditor, D S; MacDonald, M J; Kamath, M V; Bugaresti, J; Adams, M; McCartney, N; H 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

The effects of meclofenoxate on cognitiv

The effects of meclofenoxate on cognitive performance in elderly individuals with memory impairment: A placebo-controlled study

✍ Dr. S. J. Harris; J. H. Dowson 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 2 views

Twenty residents with mild to moderate memory impairment probably due to senile dementia of Alzheimer type entered a placebo-controlled, double-blind, crossover trial of meclofenoxate 600 mg administered twice daily for 12 weeks. Nine subjects completed the trial during which various tests of cognit